Shots: Astellas and Harvard enter into a 3yrs. strategic research collaboration initiated by faculty at Harvard, focused on the research and development of innovative therapeutics and technologies of mutual interest Astellas will issue one or more challenges, based on the research scopes of Astellas to inspire the research proposals by Harvard faculty. The proposals will […]Read More
Shots: oNKo-innate to receive an up front, clinical, regulatory & commercial milestones along with royalties on sales of immuno-oncology and cell therapy programs while in exchange, the company will utilize its genome-wide screening techniques and technology platform to discover novel immune cell targets enhancing NK cell anti-tumor immunity and to create NK cell therapies oNKo-innate […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
